CUSIP: 29668H104
Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,173,437
-
Share change
-
-18,982
-
Total reported value
-
$30,453,000
-
Price per share
-
$2.81
-
Number of holders
-
11
-
Value change
-
-$50,375
-
Number of buys
-
2
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 29668H104?
CUSIP 29668H104 identifies 29668H104 - ESSA PHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2016
-
Previous quarter:
Q2 2016
Recent filing periods for CUSIP 29668H104:
Institutional Holders of ESSA PHARMA INC - COM as of Q3 2016
As of 30 Sep 2016,
ESSA PHARMA INC - COM was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,173,437 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, Clarus Ventures, LLC, Omega Fund Management, LLC, AWM Investment Company, Inc., ACUTA CAPITAL PARTNERS, LLC, DAFNA Capital Management LLC, Boxer Capital, LLC, ROYAL BANK OF CANADA, and Tower Research Capital LLC (TRC).
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.